BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 51 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 52,096 | $55,672 | 3.77% |
| MACKAY SHIELDS LLC | 77,043,000 | $83,172,605 | 2.12% |
| Sonora Investment Management Group, LLC | 7,960,000 | $8,654,409 | 0.79% |
| Lombard Odier Asset Management (Europe) Ltd | 12,390,000 | $17,994,379 | 0.73% |
| BRAIDWELL LP | 19,200,000 | $20,727,568 | 0.70% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 32,064,000 | $34,615,044 | 0.60% |
| LOOMIS SAYLES & CO L P | 2,089,754 | $216,269 | 0.43% |
| Liberty Mutual Group Asset Management Inc. | 825,000 | $887 | 0.24% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,143,000 | $3,386,583 | 0.09% |
| THRIVENT FINANCIAL FOR LUTHERANS | 15,950,000 | $17,139 | 0.04% |